Moderna shares jump 6% on promising cancer vaccine trial
Cancer drug gets positive readoutPotential for personalised medicinesModerna has over 45 drugs in developmentUS biotechnology firm Moderna (MRNA:NASDAQ) was the top performer in the S&P 500 on Tuesday (9 April) jumping as much as...
10 April 2024